The study drug, CFT8634, is an investigational therapy that has been shown in animal studies to help break down the BRD9 protein,by using the body’s own protein-recycling equipment. (In short, your cells are capable of breaking down proteins into their amino acid building blocks in order to rebuild themselves again.) By breaking down the BRD9 protein, which helps your type of cancer to grow, the study drug may be able to help destroy these cancer cells in humans. The purpose of this study is to find out if treatment with the study drug is safe, to find out the acceptable dose of the...